The European Union has prepared a new list of retaliatory tariffs worth €72 billion ($84 billion) on U.S. goods, including ...

Ford's low valuation and strong FCF yield make it intriguing, but profitability and high debt remain concerns. Learn why F ...

Vertex Pharmaceuticals (VRTX) has reached a broad reimbursement agreement with NHS England for Vertex’s cystic fibrosis medicine, Alyftrek (deutivacaftor/tezacaftor/vanzacaftor).

Broadcom continues to benefit from big tech's AI spending and diversification of its business. Find out why AVGO stock is a ...

Explore H1 2025 market trends: surging platinum & gold, copper's rise on AI & EV demand, and contrarian opportunities in ...

The broader trend suggests that other market forces (such as supply shocks, demand growth, and geopolitical risk) likely play ...

The Space NK acquisition is a strategic, capital-light entry into Europe, expanding Ulta Beauty’s growth runway. Read more on ...